Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain tumor patients test custom exercise plan to boost Well-Being

NCT ID NCT07570485

Symptom relief Sponsor: Center Eugene Marquis Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a personalized exercise program is doable for adults with brain tumors. Researchers will track how many patients join and stick with the 3-month program, and measure changes in quality of life, mood, and symptoms. The goal is to see if adapted physical activity can be a practical part of care for these patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
adapted physical activity program
What this could lead to
If successful, this could show that tailored exercise is a safe and practical way to help brain tumor patients feel better and function better during treatment.
What could go wrong
This is a small, early feasibility study with no control group, so it cannot prove that exercise improves outcomes. Participation may be low due to patients' health challenges.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men or women ≥ 18 years old, * Receiving medical oncology treatment at the CLCC Eugène Marquis, * Diagnosed with a primary brain tumour, regardless of diagnosis, grade or treatment, * Possible motor, sensory, attention, concentration, or memory deficits, * Patients who accept the general terms of use for connected watches * Patients affiliated with or covered by the French social security system, * Patients who have received information and signed informed consent (or their legal representative), Exclusion Criteria: * WHO score ≥ 3 * Comprehension disorders that prevent participation in adapted physical activity * Pregnant or breastfeeding women * Patients without the necessary devices to use a smartwatch (smartphone, tablet or computer), * Patients deprived of liberty, under guardianship, or curatorship, or subject to any other administrative safeguard measure. Patients unable to comply with the study schedule for social, medical, or psychological reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brain tumor adult are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

brain cancer primary brain neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Brain tumor adult

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre Eugène Marquis

    Rennes, 35000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.